307 Results

People

  1. Old
    Old
  2. Ritter
    Ritter
  3. Allison
    Allison
  4. Rudensky
    Rudensky
  5. Gnjatic
    Gnjatic
  6. Wolchok
    Wolchok
  7. Jungbluth
    Jungbluth
  8. O'Reilly
    O'Reilly
  9. Pamer
    Pamer
  10. Yuan
    Yuan

Groups

  1. GSK Faculty (144)
  2. Department of Medicine (131)
  3. Sloan Kettering Institute Faculty (108)
  4. Sloan Kettering Institute Postdocs (90)
  5. Immunology Program Faculty (76)
  6. Hematologic Malignancies, Division of (67)
  7. Center for Hematologic Malignancies (64)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (60)
  9. Solid Tumor Oncology Division (58)
  10. Center for Molecular Imaging and Biotechnology (49)
  1. "cd4+ t lymphocyte"
Formats
  1. Journal Article (288)
  2. Review (10)
  3. Editorial (5)
  4. Research Letter (2)
  5. Conference Paper (1)
  6. Guidelines (1)
Groups
  1. GSK Faculty (144)
  2. Department of Medicine (131)
  3. Sloan Kettering Institute Faculty (108)
  4. Sloan Kettering Institute Postdocs (90)
  5. Immunology Program Faculty (76)
  6. Hematologic Malignancies, Division of (67)

More Groups

People
  1. Lloyd Old (31)
  2. Jedd Wolchok (26)
  3. Gerd Ritter (23)
  4. Alexander Rudensky (21)
  5. James Allison (21)
  6. Sacha Gnjatic (19)

More People

Years
  1. 2025 (12)
  2. 2024 (28)
  3. 2023 (12)
  4. 2022 (13)
  5. 2021 (10)
  6. 2020 (11)

More Years

Publications
  1. Blood (22)
  2. Journal of Immunology (21)
  3. Clinical Cancer Research (15)
  4. Journal of Experimental Medicine (13)
  5. Nature (11)
  6. PLoS ONE (11)

More Publications

Publishers
  1. Nature Publishing Group (40)
  2. American Society of Hematology (30)
  3. American Association for Cancer Research (27)
  4. Elsevier Inc. (22)
  5. The American Association of Immunologists, Inc (21)
  6. Cell Press (18)

More Publishers

Results (307)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation
    Review

    O’Reilly, R. J.; Prockop, S.; Oved, J. H.
    Frontiers in Immunology (2023)

    Fulltext@MSK | Save
  • SEACells infers transcriptional and epigenomic cellular states from single-cell genomics data
    Journal Article

    Persad, S.; Choo, Z. N.; Dien, C.; Sohail, N.; Masilionis, I.; Chaligné, R.; Nawy, T.; Brown, C. C.; Sharma, R.; Pe’er, I.; more...
    Nature Biotechnology (2023)

    Fulltext@MSK | Save
  • Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant
    Journal Article

    Lin, A.; Brown, S.; Chinapen, S.; Lee, Y. J.; Seo, S. K.; Ponce, D. M.; Shahid, Z.; Giralt, S.; Papanicolaou, G. A.; Perales, M. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations
    Research Letter

    Kunvarjee, B.; Bidgoli, A.; Madan, R. P.; Vidal, E.; McAvoy, D.; Hosszu, K. K.; Scaradavou, A.; Spitzer, B. G.; Curran, K. J.; Cancio, M.; more...
    Journal of Allergy and Clinical Immunology (2023)

    Fulltext@MSK | Save
  • EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance
    Journal Article

    Chibaya, L.; Murphy, K. C.; DeMarco, K. D.; Gopalan, S.; Liu, H.; Parikh, C. N.; Lopez-Diaz, Y.; Faulkner, M.; Li, J.; Morris, J. P. 4th; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
    Review

    Rudin, C. M.; Reck, M.; Johnson, M. L.; Blackhall, F.; Hann, C. L.; Yang, J. C. H.; Bailis, J. M.; Bebb, G.; Goldrick, A.; Umejiego, J.; more...
    Journal of Hematology & Oncology (2023)

    Fulltext@MSK | Save
  • Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma
    Journal Article

    Restle, D.; Dux, J.; Li, X.; Byun, A. J.; Choe, J. K.; Li, Y.; Vaghjiani, R. G.; Thomas, C.; Misawa, K.; Tan, K. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
    Journal Article

    Nabbi, A.; Danesh, A.; Espin-Garcia, O.; Pedersen, S.; Wellum, J.; Fu, L. H.; Paulson, J. N.; Geoerger, B.; Marshall, L. V.; Trippett, T.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
    Journal Article

    Hirschhorn, D.; Budhu, S.; Kraehenbuehl, L.; Gigoux, M.; Schröder, D.; Chow, A.; Ricca, J. M.; Gasmi, B.; De Henau, O.; Mangarin, L. M. B.; more...
    Cell (2023)

    Fulltext@MSK | Save
  • Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma
    Review

    Lim, M. S.; Foley, M.; Mussolin, L.; Siebert, R.; Turner, S.
    Best Practice and Research: Clinical Haematology (2023)

    Fulltext@MSK | Save